Hasbro Strengthens Ties With Disney, Stock Surges
Image courtesy of 123rf.com
Hasbro, Inc. (NYSE: HAS) has announced a significant expansion of its partnership with Disney Consumer Products (NYSE: DIS), securing global rights to produce toys and board games for the iconic Star Wars and Marvel franchises. This multi-year agreement allows Hasbro to broaden its product line, incorporating both new and classic characters from these beloved universes.
The collaboration aims to introduce innovative play experiences, further connecting fans with their favorite stories and characters. Hasbro will also integrate Marvel characters into its Magic: The Gathering trading card game, enhancing its appeal to a wider audience.
Hasbro Likely to Continue Dominating the Toy and Board Game Market
Hasbro’s renewed agreement with Disney Consumer Products marks a pivotal moment in its strategy to dominate the toy and board game market. By securing rights to globally recognized franchises like Star Wars and Marvel, Hasbro positions itself as a leader in delivering products that resonate with fans of all ages.
The collaboration will see the introduction of action figures, Lightsabers, and toys inspired by popular series such as Marvel’s Spidey and his Amazing Friends. This strategic move not only enhances Hasbro’s product diversity but also strengthens its market presence in the entertainment industry.
HAS Stock Brief
Following the announcement, Hasbro’s stock experienced a notable rise, opening at $56.946 and reaching a current price of $61.24 as of April 24, 2025. This represents a significant increase from its previous close of $52.69. The stock’s day low was recorded at $56.65, with a high of $61.39.
Over the past year, Hasbro’s stock has fluctuated between a low of $49.00 and a high of $73.46. Key financial metrics indicate a dividend yield of 5.32% and a market capitalization of over $8.5 billion. Analysts have set a target mean price of $73.51, with a strong buy recommendation, reflecting investor confidence in Hasbro’s strategic direction and financial health.
More By This Author:
Merck & Co. Reports Better Than Expected Results For First-Quarter 2025
Procter & Gamble’s Q3 FY’25 Results Fall Short Of Expectations
Bitcoin’s Price Surges As Investors Seek Safe-Haven Assets
Disclaimer: The author does not hold or have a position in any securities discussed in the article. All stock prices were quoted at the time of writing.
Comments
